Gentium S.p.A. · Villa Guardia, Como Italy · (NASDAQ (GM): GENT)
Company Description
View Gentium S.p.A. Locations On A US Map
This link will open in a new window
This link will open in a new window Gentium wants to soften the harsh effects of cancer treatment. The company seeks to minimize the damage done by cancer treatments such as chemotherapy and radiation therapy. The company's most advanced product candidates use defibrotide to relieve blood vessel disorders caused by such treatments, and could also have applications in additional inflammation and vascular disorders. Gentium also manufactures and sells active pharmaceutical ingredients, including heparin, an anticoagulant. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Gentium S.p.A. Reports
No subscription, no problem.
Download presentation-ready reports for this company now.
Download presentation-ready reports for this company now.
From company profiles to the competitive landscape, Hoover’s offers immediate access to individual reports.
Key Gentium S.p.A. Financials
| Company Type | Public - NASDAQ (GM): GENT Single Location |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $10.5 |
| 2008 Employees | 74 |
Gentium S.p.A. Executives
6 executives listed for Gentium S.p.A.'s Villa Guardia, Como location.
| Title | Name & Bio | Contact |
| Interim CEO and Director | Khalid Islam | |
| EVP and CFO | Gary Gemignani | |
| Chief Chemical Research Laboratory Officer | Danilo Moltrasio |
Competition
Top Gentium S.p.A. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!